You’re in Good Company
We invest in and support teams who deeply understand the healthcare context and can deliver the right solutions.

Leverage your plan assets and the power of AI to discover, recover, and prevent medical over billing.
- Funded
- 2025
- Entry point
- Seed

Ruby provides an AI-native clinical extension for home health that supports patients and field teams in real time. The company exists to close the gaps between agencies, payers, and patients by combining coordination, technology, payment innovation, and clinical support for every episode of care.
- Entry point
- Seed
- Co-investors
- AlleyCorp

PhaseV is a technology company harnessing the power of ML (machine learning) to innovate the drug development process, powering more efficient, advanced, and successful clinical trials.
Their proprietary platform for trial design and execution promotes the adoption of advanced dynamic clinical trials, enabling sponsors to significantly improve efficiency and effectiveness while maximizing patient benefits.
In addition, their novel causal-ML pipeline enables the detection of hidden signals in clinical trial data, identifying heterogeneous treatment effects at a much finer level than otherwise possible, and providing meaningful and actionable insights for the design of the next study, to increase trial success rate.
- Entry point
- Seed
- Co-investors
- Accel, Insight, Viola, Exor

Automate 1040 tax prep so you can focus on building your firm.
- Entry point
- Seed
- Co-investors
- Oak hc/ft, a16z, Founders Fund, Khosla Ventures, General Catalyst

Founded in 2010, Marqeta has re-engineered how payment cards, virtual cards, and mobile authorization products should be developed and deployed. The Marqeta Platform, built from the ground up with no legacy infrastructure, provides the world’s first fully documented, open API issuer processor platform. Adopters of The Marqeta Platform include leading financial services, e-commerce, retail, and social media brands.
- Entry point
- Seed
- Status
- NASDAQ: MQ

Longevitix turns fragmented patient data into a confident care strategy.
With hundreds of biomarkers, continuous wearable streams, constantly evolving literature, and no single source of truth across labs and EHRs, physicians face growing difficulty delivering personalized, proactive care.
Longevitix’s platform helps physicians convert clinical signals into decisions. The platform unifies labs, PDFs, wearables, genetics, imaging, intake forms, and clinical history into a single, prioritized care plan with ongoing patient guidance.
- Funded
- 2026
- Entry point
- Seed

Connect with your patients before, during, and after medical care with ecton – the world’s most advanced patient payments platform, powered by AI.
- Entry point
- Pre-seed
- Co-investors
- General Catalyst, UpWest

OneStep offers an AI-powered digital care platform that allows providers to assess, treat, and monitor patients remotely using smartphone sensors. By transforming everyday movements into clinically validated insights, OneStep enhances mobility, reduces falls, and improves patient engagement, while also helping providers streamline operations and generate new revenue streams.
- Funded
- 2022
- Entry point
- Round A

Jimini Health is setting a new standard in mental healthcare.
By combining evidence-based therapeutic methods with continuous, AI-supported engagement via its virtual assistant Sage™, Jimini Health offers personalized, immersive support that bridges the gap between therapy sessions.
- Funded
- 2024
- Entry point
- Seed

FundGuard is a state-of-the-art cloud-based enterprise operating platform for asset managers, asset owners, custodian banks and fund administrators to manage investments across mutual funds and ETFs, alternatives, insurance, and pension.
- Funded
- 2018
- Entry point
- Seed

Rhino is revolutionizing the way AI is created and maintained in healthcare by streamlining hospital and industry data collaborations, without compromising data privacy.
- Entry point
- Seed
- Co-investors
- AlleyCorp, Qiming, Telus

Tyto Care is developing the first FDA-approved, full stack software platform and handheld device to enable anyone, anywhere to perform an accurate physical examination for remote diagnosis at clinical-level data quality. Representing the next generation of telehealth technology, this platform powers modern health systems around the world.
- Entry point
- Seed
- Co-investors
- Insight, Tiger, Orbimed

As digital data becomes the key driver of healthcare initiatives and workflows, there’s growing risk of patient information being leaked, exposed, and exploited. Protenus helps hospitals protect patient privacy in electronic medical records by using machine intelligence to identify and apply clinical context and detect HIPAA violations in real time.
- Entry point
- Seed
- Status
- Acquired by Thoma Bravo

82 million Americans live in primary care shortage areas. Heyday Health is providing seniors with access and availability to high quality, personalized virtual and in-home primary care.
- Funded
- 2021
- Entry point
- Seed

Mana.bio is an AI based drug delivery startup, facilitating rapid “Design-Build-Test-Learn” cycles for identifying likely drug delivery vehicles for given therapeutic payloads.
- Entry point
- Seed
- Co-investors
- a16z, NFX

Nest provides healthcare organizations with the automation infrastructure needed to launch and scale longitudinal genomic programs. It offers a turnkey solution for patient identification, Clinical Decision Support, and tailored educational resources for providers and patients.
- Entry point
- Pre-seed
- Co-investors
- Casdin, DCVC, B Capital

Phrase Health are empowering teams with EHR data and collaborative tools to drive clinical quality measures and outcomes.
- Funded
- 2021
- Entry point
- Seed

C2i Genomics is the first company to offer post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
- Entry point
- Seed
- Status
- Acquired by Veracyte (NASDAQ: VCYT)

Connect with a patient mentor who has firsthand experience to support you through your treatment journey.
- Funded
- 2024
- Entry point
- Seed

Phantom Neuro is a neurotechnology company developing a minimally invasive interface that enables intuitive control of prosthetic limbs and robotic exoskeletons. Its core platform, Phantom X, is designed to restore natural movement and functionality for amputees and individuals with mobility impairments, allowing robotic devices to function as seamless extensions of the human body.
- Entry point
- Pre-seed
- Co-investors
- Draper, Ottobock, Breakout Ventures

Laguna helps eliminate administrative burdens with conversational AI, empowering care teams to focus on meaningful care and impactful conversations.
- Funded
- 2020
- Entry point
- Seed

Ovia provides a digital healthcare platform for women and families. Originally developed to help couples conceive faster and have healthier pregnancies, the company has grown to provide a suite of mobile applications for fertility, pregnancy and parenting. Its newest product line helps employers provide benefits information, programs for high-risk pregnancies and 1-on-1 health coaching to women and their families through a mobile platform.
- Funded
- 2013
- Status
- Acquired, Labcorp (NYSE: LH)

Mellie puts everything you need to plan and care for your elders all in one place. We build a personalized care plan for you to plan care, find trusted resources, and provide a dedicated care coordinator to help navigate the entire process.
- Funded
- 2022
- Entry point
- Pre-seed

Maverick’s mCoder™ Deep Learning AI understands and converts the patient charts into medical codes without coders’ involvement.
- Funded
- 2022
- Entry point
- Seed

The hassle and side effects that come along with many current invasive and pharmacological medical therapies aren’t for everyone. By combining an innovative approach to neuro-modulation with modern wireless communications and smartphone applications, Theranica is designing products with effective therapy treatments for a variety of severe and widely common medical problems – without degrading patients’ quality of life.
- Entry point
- Round A
- Co-investors
- Lightspeed, aMoon

When health and function decline with age, the result is costly for families, insurance carriers, and society at large. Assured Allies combines data science & a human centered approach to deliver the best aging outcomes for families and insurers.
- Entry point
- Seed
- Co-investors
- Harel, Hamilton Lane, Equitrust, Wilton Re

Small businesses’ number one pain point is cash flow management. Fundbox alleviates this pain by providing businesses owners and freelancers advances for their outstanding invoices. Fundbox’s platform quickly and automatically underwrites businesses and provides funds through integration with online business applications such as QuickBooks and Xero.
- Entry point
- Seed
- Co-investors
- Khosla Ventures, General Catalyst, Spark Capital

Kit Check provides automated pharmacy kit and medication processing software for hospitals. The platform delivers a 90% reduction in pharmacy-kit processing time while simultaneously increasing kit accuracy, decreasing inventory and freeing pharmacist time for clinical work.
- Entry point
- Seed
- Status
- Acquired by Thoma Bravo

Market researchers aim to maximize quality of feedback, how representative the feedback is, and how quickly the feedback can be obtained, but have traditionally had to choose between two of the three. reMesh breaks this paradigm and enables high-quality focus groups to be performed online by large groups of people, revolutionizing the way customer insights are gathered by brands and market research companies.
- Entry point
- Seed
- Co-investors
- General Catalyst

Bizzabo’s Events Cloud helps marketers create successful conferences and get the most out of their event marketing budget by empowering them to build amazing websites, sell tickets, grow and engage their communities, go mobile, coordinate attendee meetings and maximize event experiences – using a beautiful, user friendly platform.
- Entry point
- Round A
- Status
- Exited via Secondary sale

PhysIQ is improving healthcare through personalized predictive analytics, providing patients, doctors and care providers with the earliest insight into deteriorating patient health. The company offers a remote patient monitoring system with predictive analytics technology that differentiates abnormal physiological behavior from normal physiological variation for each specific patient.
- Funded
- 2013
- Entry point
- Round A

Corporate legal teams, particularly in contract-intensive companies, spend much of their time reading contracts and ensuring their compliance to internal legal policy. LawGeex is streamlining these workflows by using machine intelligence to automatically review contracts and make sure they adhere to the company’s policy, saving time and money.
- Entry point
- Seed
- Co-investors
- Aleph

Engaging every individual with hyper-personalized recommendations in the right tone, timing and real-world context every step of their unique journey with chronic conditions.
- Entry point
- Pre-seed
- Co-investors
- Phillips, Pontifax, Entree Capital, FinTLV

metaMe Health is currently developing Regulora for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora for IBS provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.
- Funded
- 2019
- Entry point
- Seed

With AI/machine learning, DNA sequencing and synthesis, biology is experiencing the move from analog to digital that the tech world experienced only a few years ago. tech.bio is seizing the massive opportunity in this biotech to Tech.Bio transition by founding and funding companies with breakout potential.
- Funded
- 2018

Rooted in decades of research and proprietary deep neuro technology, Brainvivo is the first company to digitize the human brain’s abilities and make them universally accessible. Brainvivo unlocks the sophisticated biological neural network of the human brain to expand people’s capabilities and automate tasks that require human judgment, emotional insights, and intuition.
- Funded
- 2019
- Entry point
- Seed

Genome Compiler is building the next generation of computer-aided design tools for synthetic biology. An Integrated Development Environment, Genome Compiler’s platform includes tools for designing, debugging, and compiling genetic code, just like its software equivalents. Streamlining genetic code development is critical in ushering in the age of Synthetic Biology.
- Entry point
- Round A
- Status
- Acquired by Twist Bioscience (NASDAQ: TWST)

StreamOnce transforms how teams collaborate by connecting today’s business systems into their social for enterprise system. By bringing all of the relevant information for different systems to one social place, your team can search, manage and respond instantly to data.
- Entry point
- Seed
- Status
- Acquired by Jive (NASDAQ: JIVE)

Bento is a flexible expense management platform that helps SMBs become more efficient at running their businesses, enabling them to easily raise capital, manage and control expenses.
- Entry point
- Seed
- Status
- Acquired by US Bank

Telesofia helps healthcare providers explain complex medical information (such as medication, pre-surgical or exam preparation instructions) to patients using auto-generated videos. Videos are personalized to each patient based on their demographics and specific instructions, transformed into a clear message and viewable on any internet-connected device.
- Funded
- 2013
- Entry point
- Seed

PhysiMax technology enables automated MSK and injury risk screenings with validated accuracy and their Artificial Intelligence (AI) engine generates evidence-based personal training programs based on the user’s objective scoring outcome to aid in effective injury prevention and recovery.
- Entry point
- Pre-seed
- Status
- Acquired by DarioHealth (NASDAQ: DRIO)
What does tomorrow look like?
Growing pressures on health systems and consumers mean the “old ways” won’t work anymore. The industry is changing, and the stakes are higher than ever.